Unknown

Dataset Information

0

Pre-clinical Development Of AP4B1 Gene Replacement Therapy For Hereditary Spastic Paraplegia Type 47

ABSTRACT: Image source data for figures 6 and 8 in manuscript submission.

SUBMITTER:  

PROVIDER: S-BIAD1267 | bioimages |

REPOSITORIES: bioimages

Json Xml

Similar Datasets

Unknown LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 8 of 9: Calculated dose-response metrics for biological replicate 2
2017-03-14 | LDS-1380 | LINCS
Unknown MEMA HCC1954 Staining Set 100 (Lapatinib treatment)
2016-11-10 | LDS-1477 | LINCS
Unknown LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 9 of 9: Calculated dose-response metrics for biological replicate 3
2017-03-14 | LDS-1381 | LINCS
Unknown FoxO3a nuclear-cytoplasmic pulsing dynamics in a mammary epithelial cell line following growth-factor treatment with varying ERK/AKT activation loads. Dataset 1 of 3: single-cell reporter measurements.
2017-05-02 | LDS-1382 | LINCS
Unknown EGF-induced FoxO3a nuclear-cytoplasmic pulsing dynamics in mammary epithelial cell lines following treatment with increasing doses of a MEK inhibitor. Dataset 2 of 3: single-cell reporter pulsing metrics.
2017-05-02 | LDS-1392 | LINCS
Unknown Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 4 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen class.
2017-02-01 | LDS-1365 | LINCS
Unknown MEMA PC3 Staining Set 2
2016-03-09 | LDS-1315 | LINCS
Unknown MGH (CMT) Growth Inhibition Assay Protocol (9 compound doses: 64 nM to 0.25 nM) -- DNA Staining
2014-05-30 | EDS-1009 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2.
2017-03-14 | LDS-1254 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 2 of 2: Mean cell count and mean normalized growth rate inhibition values across technical replicates.
2016-04-01 | LDS-1295 | LINCS